Last $54.72 USD
Change Today -0.23 / -0.42%
Volume 347.8K
WST On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

west pharmaceutical services (WST) Snapshot

Open
$54.72
Previous Close
$54.95
Day High
$55.09
Day Low
$54.59
52 Week High
12/19/14 - $55.29
52 Week Low
08/12/14 - $39.11
Market Cap
3.9B
Average Volume 10 Days
375.3K
EPS TTM
$1.78
Shares Outstanding
71.5M
EX-Date
04/20/15
P/E TM
30.7x
Dividend
$0.44
Dividend Yield
0.77%
Current Stock Chart for WEST PHARMACEUTICAL SERVICES (WST)

Related News

No related news articles were found.

west pharmaceutical services (WST) Related Businessweek News

No Related Businessweek News Found

west pharmaceutical services (WST) Details

West Pharmaceutical Services, Inc. develops, manufactures, and sells components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare, and consumer products industries. The company operates through two segments, Pharmaceutical Packaging Systems and Pharmaceutical Delivery Systems. The Pharmaceutical Packaging Systems segment offers packaging components and systems for injectable drug delivery, such as stoppers and seals for vials, closures and other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. This segment also provides contract analytical laboratory services for testing and evaluating primary drug-packaging components with the contained drug formulation; and specialized testing for complete drug delivery systems. The Pharmaceutical Delivery Systems segment offers safety and administration systems, and multi-component systems for drug administration. It offers customer contract-manufacturing and assembly solutions, which include technologies, such as multi-component molding, in-mold labeling, ultrasonic welding, and clean room molding and device assembly used to manufacture customer-owned components, as well as devices used in surgical, diagnostic, ophthalmic, other drug delivery systems, personal care, and consumer products. This segment’s administration systems comprise sterile devices for the administration of drug products, including transfer devices, needleless reconstitution systems, and vial adapters. The company sells its products primarily through its sales force and distribution network, as well as through contract sales agents and regional distributors in the United States, Germany, France, and other European countries. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

7,000 Employees
Last Reported Date: 02/25/15
Founded in 1923

west pharmaceutical services (WST) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $825.0K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $457.9K
President of Pharmaceutical Packaging Systems...
Total Annual Compensation: $359.3K
President of Pharmaceutical Delivery Systems
Total Annual Compensation: $339.9K
Compensation as of Fiscal Year 2013.

west pharmaceutical services (WST) Key Developments

West Pharmaceutical Services, Inc. Announces Dividend for the Second Quarter of 2015, Payable on May 6, 2015

West Pharmaceutical Services, Inc. announced that the company's Board of Directors has approved a second-quarter 2015 dividend of $0.11 per share. The dividend will be paid on May 6, 2015 to shareholders of record as of April 22, 2015.

West Pharmaceutical Services, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for the First Quarter and Full Year of 2015

West Pharmaceutical Services, Inc. announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported net sales of $349.8 million against $342.7 million a year ago. Operating profit was $44.6 million against $36.9 million a year ago. Income before income taxes was $41.7 million against $33.5 million a year ago. Net income was $31.4 million or $0.43 assuming diluted per share against $23.6 million or $0.33 assuming diluted per share a year ago. Non-GAAP operating profit was $44.6 million against $36.9 million a year ago. Adjusted net income improved 22.5% to $33.2 million, compared to $27.1 million in the 2013 quarter, and adjusted diluted EPS increased to $0.45 in the quarter, compared to $0.38 in the prior-year period. For the year, the company reported net sales of $1,421.4 million against $1,368.4 million a year ago. Operating profit was $182.0 million against $162.4 million a year ago. Income before income taxes was $169.0 million against $147.1 million a year ago. Net income was $127.1 million or $1.75 assuming diluted per share against $112.3 million or $1.57 assuming diluted per share a year ago. Non-GAAP operating profit was $183.2 million against $162.4 million a year ago. Non-GAAP net income was $162.4 million against $116.1 million a year ago. Operating cash flow was $182.9 million against $220.5 million a year ago. Capital expenditures was $111.9 million against $151.9 million a year ago. The company expected full-year 2015 consolidated net sales between $1,430 million to $1,460 million, full-year adjusted diluted EPS between $1.74 to $1.92. The Company estimates its 2015 capital spending at between $150 million and $175 million, including approximately $35 million related to the planned new facility in Waterford, Ireland. Capital spending in 2014 was $111.9 million. The company expects first quarter 2015 revenues to grow 5% to 7%, excluding currency effects, over the first quarter 2014 and for growth in adjusted diluted EPS to be in the low teens.

West Pharmaceutical Services, Inc. to Report Q4, 2014 Results on Feb 19, 2015

West Pharmaceutical Services, Inc. announced that they will report Q4, 2014 results at 9:00 AM, US Eastern Standard Time on Feb 19, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WST:US $54.72 USD -0.23

WST Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Chemed Corp $116.48 USD -0.01
Gerresheimer AG €51.38 EUR -1.08
Sirona Dental Systems Inc $90.82 USD -0.20
STERIS Corp $64.52 USD +0.23
Teleflex Inc $121.69 USD +0.47
View Industry Companies
 

Industry Analysis

WST

Industry Average

Valuation WST Industry Range
Price/Earnings 31.3x
Price/Sales 2.7x
Price/Book 4.1x
Price/Cash Flow 30.8x
TEV/Sales 2.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WEST PHARMACEUTICAL SERVICES, please visit www.westpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.